Recent News Releases
This section includes a wide variety of news including media releases, photo and video galleries, fact sheets and publications.
- Phase II study of adjuvant chemotherapy with S1 plus oxaliplatin for Chinese patients with gastric cancer
- Initial apixaban dosing in patients with atrial fibrillation
- Efficacy and safety of switching to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide (E/C/F/TAF) in virologically suppressed women
- Burden of exposure to potential interactions between antiretroviral and non-antiretroviral medications in a population of HIV-positive patients aged 50 years or older
- Alirocumab vs usual lipid-lowering care as add?on to statin therapy in individuals with type 2 diabetes and mixed dyslipidaemia: The ODYSSEY DM-DYSLIPIDEMIA randomized trial
PHARMACOLOGY
- An early view of real-world patient response to sacubitril/valsartan: A retrospective study of patients with heart failure with reduced ejection fraction
- Efficacy and safety of alirocumab in individuals with diabetes mellitus: Pooled analyses from five placebo-controlled phase 3 studies
- Dabigatran, rivaroxaban and apixaban vs high TTR warfarin in atrial fibrillation
- Aldosterone antagonist therapy and mortality in patients with ST-segment elevation myocardial infarction without heart failure: A systematic review and meta-analysis
- Impact of antithrombotic regimen on mortality, ischemic, and bleeding outcomes after transcatheter aortic valve replacement
CLINICAL PHARMACOLOGY
- Malignancy development risk in psoriatic arthritis patients undergoing treatment: A systematic review and meta-analysis
- Hepatectomy vs stereotactic body radiotherapy for primary early hepatocellular carcinoma: A propensity-matched analysis in a single institution
- Dermatofibrosarcoma Protuberans: A Retrospective Study of Clinicopathological Features and Related Akt/mTOR, STAT3, ERK, Cyclin D1, and PD-L1 Expression
- A phase II study to prevent radiation-induced rectal injury with lovastatin
- Conservative management following clinical complete response to neoadjuvant chemotherapy for muscle-invasive bladder cancer: Contemporary outcomes of a multi-institutional cohort study
ONCOLOGY
